Wheat flour fortification with folic acid: Changes in neural tube defects rates in Chile

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 8, 2012, Pages 1885-1890

  Cortés, Fanny ^a,b   Mellado, C ^a,c   Pardo, R A ^a,d   Villarroel, L A ^c   Hertrampf, E ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Anencephaly; Cephalocele; Folic acid; Neural tube defects

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; CHILE; DIET SUPPLEMENTATION; DISEASE SURVEILLANCE; ENCEPHALOCELE; FLOUR; FOOD FORTIFICATION; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; SOCIOECONOMICS; SPINA BIFIDA; STILLBIRTH; WHEAT;

CHILE; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PREVALENCE; TRITICUM;

TRITICUM AESTIVUM;

EID: 84864133138     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35430     Document Type: Article

References (36)

1. Botto LD, Lisi A, Robert-gnausia E, Erickson JD, Vollset SE, Mastro-iacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J. 2005. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working? BMJ 330:571.
2. Center for Disease Control and Prevention. 1992. Recommendations for use of folic acid to reduce the number of spina bifida cases and other neural tube defects. MMWR Morb Mortal Wkly Rep 41:1-7.
3. Center for Disease Control and Prevention. 2002. Folate status in women of childbearing age. Race/ethnicity - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 51:808-810.
4. Center for Disease Control and Prevention. 2004. Spina bifida and anencephaly before and after folic acid mandate- United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 53:362-365.
5. Chen LT, Rivera MA. 2004. The Costa Rican experience: Reduction of neural tube defects following food fortification programs. Nut Rev 62:S40-S43.
6. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural tube defects. N Engl J Med 327:1832-1835.
7. De Walle HEK, de Jong-van den Berg LTW, Cornel MC. 1999. Periconceptional folic acid intake in the northern Netherlands. Lancet 353:1187.
8. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernández B, Lee NS, Niyonsenga T. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357:135-1142.
9. Donoso SE. 2004. Reducción de la mortalidad materna en Chile de 1990-2000. Rev Panam Salud Pública/Pan Am J public Health 15:326-330.
10. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. 2005. Re-evaluation the benefits of folic acid fortification in the United Sates: Economic analysis, regulation and public health. Am J Public Health 95:1917-1922.
11. Hertrampf E, Cortés F, Erickson D, Cayazzo M, Freire W, Bailey LB, Howson C, Kauwell GP, Pfeiffer C. 2003. Consumption of folic acid-fortified bread is highly effective in improve folate status in women of reproductive age in Chile. J Nutr 133:3166-3169.
12. Hertrampf E, Cortés F. 2004. Folic acid fortification of wheat flour: Chile. Nut Rev 62:S44-S48.
13. Hertrampf E, Cortés F. 2008. National food fortification program with folic acid in Chile. Food Nutr Bull 29:S231-S237.
14. Honein MA, Paulossi LJ, Mathews TJ, Erickson JD, Wong LYC. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
15. Kim HJ, Fay M, Feuer EJ, Midthune D. 2000. Permutation test for joinpoint regression with applications to cancer rates. Stat Med 19:335-351.
16. Llanos A, Hertramp E, Cortés F, Pardo A, Grosse SD, Uauy R. 2007. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 83:295-303.
17. López-Camelo JS, Orioli IM, Dutra MG, Nazer J, Rivera N, Ojeda ME, Canessa A, Wettig E, Fontannaz AM, Mellado C, Castilla EE. 2005. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet Part A 135A:120.
18. López-Camelo J, Castilla EE, Orioli I. INAGEMP. ECLAMC. 2010. Folic acid fluor fortification: Impact on the frequencies of 52 congenital anomaly types in three South American countries. Am J Med Genet Part A 152A:2444-2458.
19. Martínez P. 2003. El Encanto de los Datos Sociodemográficos de la Inmigración en Chile, según el censo de 2002. Santiago: CEPAL. ONU.
20. Mathews TJ, Honein MA, Erickson JD. 2002. Spina bifida and anencephaly prevalence- United States, 1991-2001. MMWR 51:9-11.
21. Ministerio de Salud (MINSAL). Gobierno de Chile. I Encuesta Nacional de Salud 2003.
22. Ministerio de Salud (MINSAL). Gobierno de Chile. II Encuesta Nacional de Salud 2009.
23. Ministerio de Salud (MINSAL). Gobierno de Chile. Estadisticas de Salud, 2011.
24. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
25. National Cancer Institute. Joinpoint Regression Program, version 3.4.2. October 2009; Statistical Research and Applications Branch. National Cancer Institute.
26. Nazer J, López Camelo J, Castilla E. 2001. Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latinoamérica. Rev Med Chile 129:531-539.
27. Persad VL, Van den Hof MC, Dubé JM, Zimmer P. 2002. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 167:237-240.
28. Raats M, Thorpe L, Hurren C, Elliot K. 1998. Changing preconceptions Volumen I: The HEA folic acid campaign 1995-1998. Summary Report. Trevelyan House, London: London Health Education Authority.
29. Sánchez H, Albala C, Hertrampf E, Verdugo R, Lavados M, Castillo JL, Lera L, Uauy R. 2010. Prevalence of vitamin- B12 deficiency in older adults. Rev Méd Chile 138:44-52.
30. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Def Res (Part A) 82:211-216.
31. Scientific Committee on Human Nutrition. Nutritional and energy intake in the European Community. Brussels: European Commission. 1993.
32. Siffel C, Wong LY, Olney R, Correa A. 2003. Survival of infants diagnosed with encephalocele in Atlanta, 1979-98. Pediatr Perinatal Epidemiol 17:40-48.
33. Stevenson RE, Allen WP, Pai GS, Best R, Seaver LH, Dean J, Best R. 2000. Decline in prevalence of neural tube defects in a high risk region of the United States. Pediatrics 106:677-683.
34. Szot JM, Moreno CW. 2003. Mortalidad por aborto en Chile: Análisis epidemiológico 1985-2000. Rev Chil Obstet Ginecol 68:300-314.
35. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39.
36. Williams LJ, Rasmussen SA, Flores A, Edmons LD. 2005. Decline in the prevalence of Spina bifida and anencephaly by race/ethnicity: 1995-2002 Paediatrics 116:580-586.